Arylimidamide DB766, a Potential Chemotherapeutic Candidate for Chagas' Disease Treatment

Chagas' disease, a neglected tropical illness for which current therapy is unsatisfactory, is caused by the intracellular parasite Trypanosoma cruzi. The goal of this work is to investigate the in vitro and in vivo effects of the arylimidamide (AIA) DB766 against T. cruzi. This arylimidamide ex...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Batista, Denise da Gama Jaén, Batista, Marcos Meuser, Oliveira, Gabriel Melo de, Amaral, Patrícia Borges do, Lannes-Vieira, Joseli, Britto, Constança Carvalho, Junqueira, Angela, Lima, Marli Maria, Romanha, Alvaro José, Sales Junior, Policarpo Ademar, Stephens, Chad E., Boykin, David W., Soeiro, Maria de Nazaré Correia
Формат: Artigo
Язык:Inglês
Опубликовано: American Society for Microbiology (ASM) 2010
Предметы:
Experimental Therapeutics
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2897275/
https://ncbi.nlm.nih.gov/pubmed/20457822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01617-09
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы